Page last updated: 2024-08-25

almagate and Myopia, Degenerative

almagate has been researched along with Myopia, Degenerative in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kitagawa, T; Yuzawa, M1
Akagi-Kurashige, Y; Kumagai, K; Matsuda, F; Miyake, M; Nakanishi, H; Nakata, I; Oishi, A; Tsujikawa, A; Yamada, R; Yamashiro, K; Yoshimura, N1
Chiosi, F; Costagliola, C; DellʼOmo, R; Menzione, M; Parmeggiani, F; Rinaldi, M; Romano, MR; Semeraro, F1
Bennett, MD; Yee, W1

Trials

2 trial(s) available for almagate and Myopia, Degenerative

ArticleYear
[Intravitreal pegaptanib sodium for myopic choroidal neovascularization: 1 year results of a prospective pilot study].
    Nippon Ganka Gakkai zasshi, 2013, Volume: 117, Issue:4

    Topics: Adult; Aged; Aptamers, Nucleotide; Choroidal Neovascularization; Female; Humans; Male; Middle Aged; Myopia, Degenerative; Pilot Projects; Prospective Studies; Retinal Vessels; Treatment Outcome

2013
Intravitreal pegaptanib sodium (Macugen) for treatment of myopic choroidal neovascularization: a morphologic and functional study.
    Retina (Philadelphia, Pa.), 2013, Volume: 33, Issue:2

    Topics: Angiogenesis Inhibitors; Aptamers, Nucleotide; Choroidal Neovascularization; Female; Fovea Centralis; Humans; Intravitreal Injections; Male; Middle Aged; Myopia, Degenerative; Pilot Projects; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity; Visual Field Tests; Visual Fields

2013

Other Studies

2 other study(ies) available for almagate and Myopia, Degenerative

ArticleYear
Vascular endothelial growth factor gene and the response to anti-vascular endothelial growth factor treatment for choroidal neovascularization in high myopia.
    Ophthalmology, 2014, Volume: 121, Issue:1

    Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Axial Length, Eye; Bevacizumab; Choroidal Neovascularization; Female; Fluorescein Angiography; Genotype; Humans; Male; Middle Aged; Myopia, Degenerative; Ophthalmoscopy; Pharmacogenetics; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Ranibizumab; Retrospective Studies; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity

2014
Pegaptanib for myopic choroidal neovascularization in a young patient.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2007, Volume: 245, Issue:6

    Topics: Adult; Angiogenesis Inhibitors; Aptamers, Nucleotide; Capillary Permeability; Choroidal Neovascularization; Female; Fluorescein Angiography; Humans; Myopia, Degenerative; Prognosis; Vascular Endothelial Growth Factor A; Visual Acuity

2007